Denali Therapeutics DNLI
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 14.52 | 108.30 | -0.74 | -137,434 | -127 | |
| 2025Q2 | 13.99 | 108.74 | -0.72 | -134,963 | -124 | |
| 2025Q1 | 13.60 | 109.48 | -0.78 | -145,580 | -133 | |
| 2024Q4 | 20.38 | 113.22 | -0.68 | -129,846 | -115 | |
| 2024Q3 | 29.13 | 114.92 | -0.63 | -123,187 | -107 | |
| 2024Q2 | 23.22 | 117.74 | -0.58 | -116,593 | -99 | |
| 2024Q1 | 20.52 | 129.91 | -0.68 | -132,252 | -102 | |
| 2023Q4 | 21.46 | 110.99 | -0.87 | -132,572 | -119 | |
| 2023Q3 | 20.63 | 114.54 | -0.71 | -113,795 | -99 | |
| 2023Q2 | 29.51 | 92.97 | 1.32 | 170,483 | 183 | |
| 2023Q1 | 23.04 | 110.05 | -0.80 | -120,815 | -110 | |
| 2022Q4 | 27.81 | 106.75 | -0.75 | -105,344 | -99 | |
| 2022Q3 | 30.69 | 104.05 | -0.84 | -107,486 | -103 | |
| 2022Q2 | 29.43 | 104.51 | -0.48 | -61,416 | -59 | |
| 2022Q1 | 32.17 | 101.96 | -0.53 | -66,498 | -65 | |
| 2021Q4 | 44.60 | 101.69 | -0.62 | -77,121 | -75 | |
| 2021Q3 | 50.45 | 101.19 | 207.57 | -0.69 | -85,593 | -85 |
| 2021Q2 | 78.44 | 101.86 | -0.50 | -61,817 | -61 | |
| 2021Q1 | 57.10 | 101.68 | -0.58 | -71,220 | -70 | |
| 2020Q4 | 83.76 | 99.34 | 141.20 | 2.28 | 244,078 | 245 |